Bernard Klein

22.2k total citations · 1 hit paper
390 papers, 17.4k citations indexed

About

Bernard Klein is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Bernard Klein has authored 390 papers receiving a total of 17.4k indexed citations (citations by other indexed papers that have themselves been cited), including 176 papers in Hematology, 143 papers in Molecular Biology and 109 papers in Oncology. Recurrent topics in Bernard Klein's work include Multiple Myeloma Research and Treatments (156 papers), Immunotherapy and Immune Responses (47 papers) and Monoclonal and Polyclonal Antibodies Research (46 papers). Bernard Klein is often cited by papers focused on Multiple Myeloma Research and Treatments (156 papers), Immunotherapy and Immune Responses (47 papers) and Monoclonal and Polyclonal Antibodies Research (46 papers). Bernard Klein collaborates with scholars based in France, Germany and United States. Bernard Klein's co-authors include Régis Bataille, John De Vos, M Jourdan, Jean‐François Rossi, Jérôme Moreaux, Michel Jourdan, Thierry Rème, Dirk Hose, Karin Tarte and XG Zhang and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Bernard Klein

378 papers receiving 16.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6

1989 650 citations Bernard Klein, M Jourdan et al. profile →

Peers

Countries citing papers authored by Bernard Klein

Since Specialization

Citations

This map shows the geographic impact of Bernard Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Klein more than expected).

Fields of papers citing papers by Bernard Klein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Klein. The network helps show where Bernard Klein may publish in the future.

Co-authorship network of co-authors of Bernard Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Klein. A scholar is included among the top collaborators of Bernard Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Klein. Bernard Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells 2019 ·Cancers ·Claire Gourzonès, Céline Bellanger, Sylvain Lamure, (unknown), (unknown), Laure Vincent, Guillaume Cartron, Bernard Klein, Jérôme Moreaux	26
2	Development of Gene Expression–Based Score to Predict Sensitivity of Multiple Myeloma Cells to DNA Methylation Inhibitors 2012 ·Molecular Cancer Therapeutics ·Jérôme Moreaux, Thierry Rème, (unknown), Jean‐Luc Veyrune, Guilhem Requirand, Hartmut Goldschmidt, Dirk Hose, Bernard Klein	39
3	Bioactivity and Prognostic Significance of Growth Differentiation Factor GDF15 Secreted by Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma 2012 ·Cancer Research ·Jill Corre, (unknown), Nicolas Espagnolle, Benjamin Hébraud, Hervé Avet‐Loiseau, Murielle Roussel, Anne Huynh, Mélanie Gadelorge, Pierre Cordelier, Bernard Klein, Philippe Moreau, Thierry Façon, Jean‐Jacques Fournié, Michel Attal, Philippe Bourin	76
4	Gene Expression Profiling in Multiple Myeloma—Reporting of Entities, Risk, and Targets in Clinical Routine 2011 ·Clinical Cancer Research ·Tobias Meißner, Anja Seckinger, Thierry Rème, Thomas Hielscher, Thomas Möhler, Kai Neben, Hartmut Goldschmidt, Bernard Klein, Dirk Hose	30
5	Genes with a spike expression are clustered in chromosome (sub)bands and spike (sub)bands have a powerful prognostic value in patients with multiple myeloma 2011 ·Haematologica ·(unknown), Dirk Hose, Jérôme Moreaux, Brian A. Walker, Alexei Protopopov, Thierry Rème, Franck Pellestor, Véronique Pantesco, A. Jauch, Gareth J. Morgan, Hartmut Goldschmidt, Bernard Klein	41
6	Amazonia!: An Online Resource to Google and Visualize Public Human whole Genome Expression Data 2010 ·(unknown), Saïd Assou, Sylvie Tondeur, Ludovic Lhermitte, Ned Lamb, Thierry Rème, Véronique Pantesco, S. Hamamah, Bernard Klein, John De Vos	49
7	T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody 2010 ·Haematologica ·Mounia S. Braza, Bernard Klein, Geneviève Fiol, Jean François Rossi	59
8	Gene expression of anti‐ and pro‐apoptotic proteins in malignant and normal plasma cells 2009 ·British Journal of Haematology ·Michel Jourdan, Thierry Rème, Hartmut Goldschmidt, Geneviève Fiol, Véronique Pantesco, John De Vos, Jean‐François Rossi, Dirk Hose, Bernard Klein	61
9	Increased Plasma-Immune Cytokines throughout the High-Dose Melphalan-Induced Lymphodepletion in Patients with Multiple Myeloma: A Window for Adoptive Immunotherapy 2009 ·The Journal of Immunology ·Maud Condomines, Jean‐Luc Veyrune, Marion Larroque, Philippe Quittet, (unknown), (unknown), (unknown), Tarik Kanouni, Jean‐François Rossi, Bernard Klein	33
10	Gene Expression Profiling and Real-Time PCR Analyses Identify Novel Potential Cancer-Testis Antigens in Multiple Myeloma 2009 ·The Journal of Immunology ·Maud Condomines, Dirk Hose, Thierry Rème, Guilhem Requirand, Michael Hundemer, Matthieu Schoenhals, Hartmut Goldschmidt, Bernard Klein	26
11	γδ T Lymphocytes Count Is Normal and Expandable in Peripheral Blood of Patients with Follicular Lymphoma, Whereas It Is Decreased in Tumor Lymph Nodes Compared with Inflammatory Lymph Nodes 2009 ·The Journal of Immunology ·Mounia S. Braza, Anouk Caraux, Thérèse Rousset, (unknown), Hélène Sicard, Patrick Squiban, Valérie Costes, Bernard Klein, Jean‐François Rossi	15
12	Embryonic stem cell markers expression in cancers 2009 ·Biochemical and Biophysical Research Communications ·Matthieu Schoenhals, Alboukadel Kassambara, John De Vos, Dirk Hose, Jérôme Moreaux, Bernard Klein	207
13	Functional Regulatory T Cells Are Collected in Stem Cell Autografts by Mobilization with High-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor 2006 ·The Journal of Immunology ·Maud Condomines, Philippe Quittet, Zhao‐Yang Lu, (unknown), (unknown), Ernesto López, Marion Baudard, Guilhem Requirand, Christophe Duperray, Jean‐François Schved, Jean‐François Rossi, Karin Tarte, Bernard Klein	47
14	An Agonist Anti-Human CD40 Monoclonal Antibody that Induces Dendritic Cell Formation and Maturation and Inhibits Proliferation of a Myeloma Cell Line 1999 ·Hybridoma ·Zhao‐Hua Zhou, Junfeng Wang, (unknown), (unknown), Jonathan Z. Pan, Wei Xie, (unknown), Bernard Klein, (unknown)	35
15	Functional interaction of the gp80 and gp130IL-6 receptors in human B cell malignancies 1998 ·Clinical & Laboratory Haematology ·Tupitsyn Nn, (unknown), J Gaillard, (unknown), (unknown), Jean‐Pierre Liautard, Christophe Duperray, Bernard Klein, J Brochier	7
16	The Significance of Soluble lnterleukin-2, Soluble Interleuk in-2 Receptors, Soluble ICAM-1 and β<sub>2</sub>-Microglobulin in Breast Cancer Patients 1995 ·Tumor Biology ·Bernard Klein, (unknown), B. Kfir, Moshe Mishaeli, J. Shapira, Teri E. Klein	24
17	Pharmacokinetics of Interleukin-6 During Therapy with Anti-Interleukin-6 Monoclonal Antibodies: Enhanced Clearance of Interleukin-6 by a Combination of Three Anti-Interleukin-6 Antibodies 1994 ·Journal of Interferon Research ·Félix A. Montero‐Julian, Emmanuel Gautherot, John Wijdenes, Bernard Klein, Hervé Brailly	19
18	Interleukin-6 is a Major Myeloma Cell Growth Factor In Vitro and In Vivo Especially in Patients with Terminal Disease 1990 ·Current topics in microbiology and immunology ·Bernard Klein, (unknown), M Jourdan, M Portier, Régis Bataille	29
19	No detectable malignant B cells in the peripheral blood of patients with multiple myeloma 1989 ·British Journal of Haematology ·(unknown), Bernard Klein, Thérèse Commes, N. Ghanem, Marie‐Paule Lefranc, Régis Bataille	33
20	Production of B‐cell growth factor interleukin 2 and gamma interferon by peripheral blood lymphocytes from patients with chronic lymphocytic leukemia of B‐cell type 1988 ·American Journal of Hematology ·Jean‐François Rossi, Thérèse Commes, Jean Grenier, Michel Jourdan, (unknown), Bernard Klein	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact